C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,871,191 Use of IL-15 preparations to treat lymphopenia Aug 13, 10 Oct 28, 14 , THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
8,871,192 IL-1F8 polypeptides Jun 11, 13 Oct 28, 14 , AMGEN INC.
8,871,201 Stabilizing formulations Aug 12, 05 Oct 28, 14 , WYETH LLC
8,871,202 Prevention and treatment of pain using antibodies to sphingosine-1-phosphate Sep 27, 11 Oct 28, 14 , LPATH, INC.
8,871,203 Method of treating a pathological syndrome and a pharmaceutical agent May 08, 13 Oct 28, 14 , Not available
8,871,205 Methods and compositions for the treatment of immune disorders Nov 23, 10 Oct 28, 14 , THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
8,871,206 Anti-human folate receptor beta antibodies and methods of use Mar 08, 13 Oct 28, 14 , PURDUE RESEARCH FOUNDATION; THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES;
8,871,207 Neutralizing anti-influenza A virus antibodies and uses thereof Jul 18, 11 Oct 28, 14 , HUMABS, LLC.
8,871,209 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or Activin A Nov 14, 12 Oct 28, 14 , REGENERON PHARMACEUTICALS, INC.
8,871,213 infection Aug 28, 09 Oct 28, 14 , ORAL HEALTH AUSTRALIA PTY LTD
8,871,214 immunogens Jul 16, 10 Oct 28, 14 , NOVARTIS AG
8,871,215 Flagellin related polypeptides and uses thereof May 21, 14 Oct 28, 14 , CLEVELAND CLINIC FOUNDATION
8,871,216 Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases Nov 05, 12 Oct 28, 14 , IBC PHARMACEUTICALS, INC.
8,871,221 Methods of stimulating protective immunity employing Dengue viral antigens Oct 10, 13 Oct 28, 14 , VAXINNATE CORPORATION
8,871,223 HSV-1 and HSV-2 vaccines and methods of use thereof Sep 07, 07 Oct 28, 14 , THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
8,871,447 Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence Sep 12, 03 Oct 28, 14 , THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
8,871,452 Methods for treatment of cardiovascular disease Mar 07, 13 Oct 28, 14 , THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
8,871,455 Biomarker panels for assessing radiation injury and exposure Jun 12, 07 Oct 28, 14 , THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC.
8,871,467 Polynucleotides encoding antibodies that bind both IL-17A and IL-17F Jun 05, 13 Oct 28, 14 , ZYMOGENETICS, INC.
8,871,468 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins May 31, 11 Oct 28, 14 , OHIO UNIVERSITY

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2014/0322,129 ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES Mar 13, 14 Oct 30, 14 , GENENTECH, INC.
2014/0322,130 SPECIFIC BINDING PROTEINS AND USES THEREOF Mar 26, 14 Oct 30, 14 , LUDWIG INSTITUTE FOR CANCER RESEARCH LTD.
2014/0322,131 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma Jul 18, 14 Oct 30, 14 , Not available
2014/0322,132 FRAGMENTS OF P97 AND USES THEREOF Mar 13, 14 Oct 30, 14 , Not available
2014/0322,160 METHOD AND COMPOSITION FOR ALTERING A B CELL MEDIATED PATHOLOGY Dec 05, 13 Oct 30, 14 , MMRGLOBAL, INC.
2014/0322,161 ANTI-IL-6 VACCINE COMPOSITION Aug 09, 12 Oct 30, 14 , PEPTINOV SAS
2014/0322,163 NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE Dec 10, 12 Oct 30, 14 , THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERV
2014/0322,183 TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Mar 15, 14 Oct 30, 14 , Not available
2014/0322,192 PROTEOGLYCAN DEGRADING MUTANTS FOR TREATMENT OF CNS Feb 24, 14 Oct 30, 14 , ACORDA THERAPEUTICS, INC.
2014/0322,199 METHODS OF TREATING CARDIOVASCULAR AND METABOLIC DISEASES Aug 06, 12 Oct 30, 14 , THE BRIGHAM AND WOMEN'S HOSPITAL INC.
2014/0322,201 METHODS OF TREATING MULTIPLE MYELOMA USING COMBINATION THERAPIES BASED ON ANTI-CS1 ANTIBODIES Dec 23, 13 Oct 30, 14 , Not available
2014/0322,202 TREATMENT WITH ANTI ErbB2 ANTIBODIES Dec 26, 13 Oct 30, 14 , GENENTECH, INC.
2014/0322,203 FORMULATIONS WITH REDUCED OXIDATION Mar 13, 14 Oct 30, 14 , GENENTECH INC.
2014/0322,204 TREATMENT AND PREVENTION OF VIRAL INFECTIONS Mar 21, 14 Oct 30, 14 , MEDICAL RESEARCH COUNCIL
2014/0322,205 RTEF-1 VARIANTS AND THE USE THEREOF FOR INHIBITION OF ANGIOGENESIS May 05, 14 Oct 30, 14 , RESEARCH DEVELOPMENT FOUNDATION
2014/0322,206 METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION Jul 07, 14 Oct 30, 14 , ALLERGAN, INC.
2014/0322,208 TREATMENT OF HEMATOLOGIC MALIGNANCIES WITH AN ANTI-CXCR4 ANTIBODY Nov 09, 12 Oct 30, 14 , Not available
2014/0322,209 ADMINISTRATION OF ALPHA4BETA7 HETERO- DIMER-SPECIFIC ANTIBODY Nov 21, 12 Oct 30, 14 , AMGEN INC.
2014/0322,210 ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION Dec 05, 12 Oct 30, 14 , Not available
2014/0322,211 TENASCIN-C AND USE THEREOF IN RHEUMATOID ARTHRITIS Dec 12, 12 Oct 30, 14 , Not available

more results

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL